股本结构
单位：万股
| 公告日期 | 2024-03-28 | 2024-02-09 | 2024-02-01 | 2023-12-29 | 2023-11-13 | 2023-08-14 |
|---|---|---|---|---|---|---|
| 证券总股本 | 195.82 | 195.12 | 35.12 | 29.23 | 2386.24 | 2386.24 |
| 普通股本 | 195.82 | 195.12 | 35.12 | 29.23 | 2386.24 | 2386.24 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 0.02 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-20 | 2024-02-12 | 2024-01-30 | 2024-01-03 | 2023-09-30 | 2023-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-03-28 | 195.82 | 未披露 | 定期报告 | 2024-03-20 |
| 2024-02-09 | 195.12 | 未披露 |
更多>>
Common stock offered 1,600,000 shares by the company
|
2024-02-12 |
| 2024-02-01 | 35.12 | 未披露 | 定期报告 | 2024-01-30 |
| 2023-12-29 | 29.23 | 未披露 |
更多>>
Tenax Therapeutics, Inc. announced that it will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-80.
|
2024-01-03 |
| 2023-11-13 | 2386.24 | 0.02 | 定期报告 | 2023-09-30 |
| 2023-08-14 | 2386.24 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of warrants, cashless
|
2023-06-30 |
| 2023-05-15 | 2177.74 | 0.02 |
更多>>
From December 31. 2022 to March 31, 2023
Public offering sale of common stock and warrants, net of placement fees
Exercise of pre-funded warrants for cash
Exercise of pre-funded warrants, cashless
Exercise of warrants, cashless
Stock split and fractional shares issued
|
2023-03-31 |
| 2023-02-06 | 230.57 | 未披露 | 定期报告 | 2023-01-27 |
| 2023-01-04 | 229.18 | 未披露 |
更多>>
Tenax Therapeutics, Inc. announced today that it will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20. The reverse stock split will become effective at 5:00 pm Eastern Time on January 4, 2023.
|
2023-01-05 |
| 2023-01-04 | 4583.62 | 未披露 | 定期报告 | 2023-01-04 |
| 2022-11-10 | 4469.62 | 未披露 | 定期报告 | 2022-11-07 |
| 2022-11-10 | 2998.02 | 0.02 |
更多>>
From June 30, 2022 to September 30, 2022
Exercise of pre-funded warrants
|
2022-09-30 |
| 2022-03-29 | 2520.69 | 0.02 |
更多>>
From December 31, 2020 to December 31, 2021
Common stock and preferred stock issued for asset acquisition
Common stock issued for convertible preferred stock
Exercise of warrants
Exercise of stock options
|
2021-12-31 |
| 2021-11-15 | 2520.69 | 未披露 | 定期报告 | 2021-11-12 |
| 2021-08-16 | 2520.13 | 0.02 |
更多>>
From March 31, 2021 to June 30, 2021
Common stock issued for convertible preferred stock
|
2021-06-30 |
| 2021-05-17 | 1496.93 | 1.04 |
更多>>
From December 31, 2020 To March 31, 2021
Common stock and preferred stock issued for asset acquisition
Exercise of warrants
|
2021-03-31 |
| 2021-03-31 | 1496.93 | 未披露 | 定期报告 | 2021-03-25 |
| 2020-11-16 | 1261.94 | 0.02 |
更多>>
From June 30, 2020 to September 30, 2020
Common stock and pre-funded warrants sold, net of offering costs
|
2020-09-30 |
| 2020-07-08 | 1261.94 | 未披露 |
更多>>
1.Common stock offered by the company 2,523,611 shares of common stock.
2.The number of shares of common stock that will be outstanding immediately after this offering is based on 10,095,758 shares outstanding as of July 6, 2020.
|
2020-07-08 |
| 2020-08-14 | 1009.58 | 0.02 |
更多>>
From March 31, 2020 to June 30, 2020
Exercise of warrants
|
2020-06-30 |
| 2020-04-29 | 921.86 | 未披露 | 定期报告 | 2020-04-24 |
| 2020-05-15 | 800.82 | 0.02 |
更多>>
From December 31, 2019 to March 31, 2020
Common stock issued for convertible preferred stock
Common stock and pre-funded warrants sold, net of offering costs
Common stock issued for services rendered
Exercise of warrants
|
2020-03-31 |
| 2020-03-13 | 760.82 | 未披露 | 定期报告 | 2020-03-13 |
| 2019-11-14 | 674.19 | 3.86 |
更多>>
From June 30, 2019 to September 30, 2019
Common stock issued for services rendered
|
2019-09-30 |
| 2019-08-14 | 674.19 | 未披露 | 定期报告 | 2019-08-09 |
| 2019-08-14 | 667.04 | 3.86 |
更多>>
from March 31, 2019 to June 30, 2019
Common stock issued for convertible preferred stock
|
2019-06-30 |
| 2019-05-15 | 619.32 | 未披露 | 定期报告 | 2019-05-10 |
| 2019-05-15 | 615.44 | 55.46 |
更多>>
from December 31, 2018 to March 31, 2019
Common stock issued for convertible preferred stock
Compensation on options and restricted stock issued
Exercise of warrants
|
2019-03-31 |
| 2019-04-01 | 615.44 | 未披露 | 定期报告 | 2019-03-27 |
| 2019-04-01 | 379.22 | 285.46 |
更多>>
from December 31, 2017 to December 31, 2018
Preferred stock sold, net of offering costs
Common stock issued for convertible preferred stock
Compensation on options and restricted stock issued
Common stock issued for services rendered
Fractional shares of common stock due to reverse stock split
|
2018-12-31 |
| 2018-08-14 | 146.55 | 未披露 | 定期报告 | 2018-08-10 |
| 2018-08-14 | 145.37 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-04-20 | 145.36 | 未披露 | 定期报告 | 2018-04-16 |
| 2018-05-15 | 145.37 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-04-02 | 142.80 | 未披露 | 定期报告 | 2018-03-28 |
| 2018-04-02 | 141.18 | 未披露 |
更多>>
from December 31, 2016 to February 26, 2018
Compensation on options and restricted stock issued
On February 22, 2018, Tenax Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Certificate of Incorporation (the “Amendment”) to effect a reverse stock split of the Company’s common stock at a ratio of one-for-twenty (the “Reverse Stock Split”) with the Secretary of State of the State of Delaware. The Amendment did not change the number of authorized shares, or the par value, of the Company’s common stock. The Amendment provides that the Reverse Stock Split becomes effective on February 23, 2018 at 5:00 p.m., at which time every twenty shares of the Company’s issued and outstanding common stock will automatically be combined into one issued and outstanding share of the Company’s common stock.
|
2018-02-26 |
| 2018-01-16 | 2823.68 | 未披露 | 定期报告 | 2017-12-28 |
| 2017-08-09 | 2823.65 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-05-10 | 2823.65 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-03-16 | 2812.00 | 未披露 |
更多>>
From December 31, 2015 to December 31, 2016
Compensation on options and restricted stock issued
|
2016-12-31 |
| 2016-11-09 | 2811.99 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-08-09 | 2811.98 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-05-10 | 2811.98 | 未披露 | 定期报告 | 2016-03-31 |
| 2016-03-14 | 2811.98 | 未披露 | 定期报告 | 2016-03-09 |
| 2016-03-14 | 2811.97 | 未披露 |
更多>>
from April 30, 2015 to December 31, 2015
Compensation on options and restricted stock issued
|
2015-12-31 |
| 2015-12-10 | 2811.97 | 未披露 | 定期报告 | 2015-10-31 |
| 2015-09-09 | 2811.96 | 未披露 | 定期报告 | 2015-07-31 |
| 2015-07-14 | 2811.95 | 未披露 |
更多>>
from April 30, 2014 to April 30, 2015
Compensation on options and restricted stock issued
Common stock issued for services rendered
Common stock issued as interest on convertible debt
Exercise of warrants
|
2015-04-30 |
| 2015-03-17 | 2811.94 | 未披露 | 定期报告 | 2015-01-31 |
| 2014-12-15 | 2811.94 | 未披露 | 定期报告 | 2014-10-31 |
| 2014-09-15 | 2810.73 | 未披露 | 定期报告 | 2014-07-31 |
| 2014-07-29 | 2810.72 | 未披露 | 定期报告 | 2014-07-24 |
| 2014-06-02 | 2785.82 | 未披露 | 定期报告 | 2014-05-29 |
| 2014-07-29 | 2785.80 | 未披露 |
更多>>
from April 30, 2013 to April 30, 2014
Preferred stock sold, net of offering costs
Preferred stock issued for convertible debt
Common and preferred stock issued for asset purchase
Common stock sold, net of offering costs
Common stock issued for convertible preferred stock
Common stock issued as interest on convertible debt
Common stock issued as dividend on convertible preferred stock
Compensation on options and restricted stock issued
Common stock issued for services rendered
Exercise of warrants
Fractional shares of common stock due to reverse stock split
1-for-20 reverse stock split effective May 10, 2013
|
2014-04-30 |
| 2014-03-17 | 1715.35 | 未披露 | 定期报告 | 2014-03-14 |
| 2014-03-17 | 1367.11 | 3.32 | 定期报告 | 2014-01-31 |
| 2013-12-17 | 1062.38 | 未披露 | 定期报告 | 2013-12-16 |
| 2013-12-17 | 681.43 | 0.50 | 定期报告 | 2013-10-31 |
| 2013-11-04 | 544.53 | 未披露 | 定期报告 | 2013-10-18 |
| 2013-10-04 | 541.44 | 未披露 | 定期报告 | 2013-10-03 |
| 2013-09-17 | 505.11 | 未披露 | 定期报告 | 2013-09-13 |
| 2013-09-17 | 306.22 | 0.46 | 定期报告 | 2013-07-31 |
| 2013-07-17 | 212.44 | 未披露 | 定期报告 | 2013-07-15 |
| 2013-06-26 | 209.68 | 未披露 | 定期报告 | 2013-06-20 |
| 2013-06-26 | 193.01 | 0.10 |
更多>>
from April 30, 2012 to May 13, 2013
Preferred stock sold, net of offering costs
Common stock issued for convertible preferred stock
Common stock issued as interest on convertible debt
Common stock issued as dividend on convertible preferred stock
Compensation on options and restricted stock issued
Issuance of warrants
Exchange of warrants
Fractional shares of common stock due to reverse stock split
As of June 3, 2013, we have regained compliance with the minimum $1.00 bid price requirement, due in part to our 20-to-1 reverse stock split effected on May 10, 2013.
|
2013-05-13 |
| 2013-04-12 | 3859.98 | 未披露 | 定期报告 | 2013-04-10 |
| 2013-03-18 | 3830.58 | 未披露 | 定期报告 | 2013-03-15 |
| 2013-03-18 | 3365.05 | 未披露 | 定期报告 | 2013-01-31 |
| 2012-12-14 | 3313.39 | 未披露 | 定期报告 | 2012-12-12 |
| 2012-12-14 | 3289.99 | 未披露 | 定期报告 | 2012-10-31 |
| 2012-09-19 | 3232.85 | 未披露 | 定期报告 | 2012-09-18 |
| 2012-07-25 | 3106.65 | 0.18 | 定期报告 | 2012-07-20 |
| 2012-07-25 | 2941.77 | 未披露 |
更多>>
from April 30, 2011 to April 30, 2012
Common stock sold, net of offering costs
Common stock issued for convertible preferred stock
Common stock issued as interest on convertible debt
Common stock issued as dividend on convertible preferred stock
Compensation on options and restricted stock issued
Exercise of warrants and options
|
2012-04-30 |
| 2012-03-15 | 2901.93 | 0.18 | 定期报告 | 2012-03-15 |
| 2012-03-15 | 2901.93 | 未披露 | 定期报告 | 2012-03-13 |
| 2012-03-15 | 2823.55 | 未披露 | 定期报告 | 2012-01-31 |
| 2011-12-15 | 2739.59 | 未披露 | 定期报告 | 2011-12-13 |
| 2011-12-15 | 2385.77 | 未披露 | 定期报告 | 2011-10-31 |
| 2011-09-19 | 2377.13 | 未披露 | 定期报告 | 2011-09-14 |
| 2011-09-19 | 2340.01 | 未披露 | 定期报告 | 2011-07-31 |
| 2011-07-15 | 2339.33 | 未披露 |
更多>>
from April 30 2010 to April 30 2011
Common stock sold, net of offering costs
Common stock issued for convertible debt
Issuance of common stock to employees
Exercise of warrants and options
|
2011-04-30 |
| 2011-03-21 | 2339.22 | 未披露 | 定期报告 | 2011-03-14 |
| 2011-03-21 | 2339.17 | 未披露 | 定期报告 | 2011-01-31 |
| 2010-12-09 | 2339.12 | 未披露 | 定期报告 | 2010-12-03 |
| 2010-12-09 | 2339.02 | 未披露 | 定期报告 | 2010-10-31 |
| 2010-09-09 | 2338.70 | 未披露 | 定期报告 | 2010-09-03 |
| 2010-09-09 | 2338.65 | 未披露 | 定期报告 | 2010-07-31 |
| 2010-07-23 | 2337.63 | 未披露 | 定期报告 | 2010-07-20 |
| 2010-07-23 | 2145.73 | 未披露 |
更多>>
from April 30, 2009 to April 30, 2010
Common stock sold, net of offering costs
Common stock issued for convertible debt
Issuance of common stock to employees
Issuance of common stock for services rendered
Exchange of warrants
Exercise of warrants and options
Fractional shares of common stock due to reverse stock split
|
2010-04-30 |
| 2010-03-19 | 2131.07 | 未披露 | 定期报告 | 2010-03-15 |
| 2010-03-19 | 2130.95 | 未披露 | 定期报告 | 2010-01-31 |
Common stock offered 1,600,000 shares by the company
Tenax Therapeutics, Inc. announced that it will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-80.
From March 31, 2023 to June 30, 2023
Exercise of warrants, cashless
From December 31. 2022 to March 31, 2023
Public offering sale of common stock and warrants, net of placement fees
Exercise of pre-funded warrants for cash
Exercise of pre-funded warrants, cashless
Exercise of warrants, cashless
Stock split and fractional shares issued
Tenax Therapeutics, Inc. announced today that it will be executing a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20. The reverse stock split will become effective at 5:00 pm Eastern Time on January 4, 2023.
From June 30, 2022 to September 30, 2022
Exercise of pre-funded warrants
From December 31, 2020 to December 31, 2021
Common stock and preferred stock issued for asset acquisition
Common stock issued for convertible preferred stock
Exercise of warrants
Exercise of stock options
From March 31, 2021 to June 30, 2021
Common stock issued for convertible preferred stock
From December 31, 2020 To March 31, 2021
Common stock and preferred stock issued for asset acquisition
Exercise of warrants
From June 30, 2020 to September 30, 2020
Common stock and pre-funded warrants sold, net of offering costs
1.Common stock offered by the company 2,523,611 shares of common stock.
2.The number of shares of common stock that will be outstanding immediately after this offering is based on 10,095,758 shares outstanding as of July 6, 2020.
From March 31, 2020 to June 30, 2020
Exercise of warrants
From December 31, 2019 to March 31, 2020
Common stock issued for convertible preferred stock
Common stock and pre-funded warrants sold, net of offering costs
Common stock issued for services rendered
Exercise of warrants
From June 30, 2019 to September 30, 2019
Common stock issued for services rendered
from March 31, 2019 to June 30, 2019
Common stock issued for convertible preferred stock
from December 31, 2018 to March 31, 2019
Common stock issued for convertible preferred stock
Compensation on options and restricted stock issued
Exercise of warrants
from December 31, 2017 to December 31, 2018
Preferred stock sold, net of offering costs
Common stock issued for convertible preferred stock
Compensation on options and restricted stock issued
Common stock issued for services rendered
Fractional shares of common stock due to reverse stock split
from December 31, 2016 to February 26, 2018
Compensation on options and restricted stock issued
On February 22, 2018, Tenax Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Certificate of Incorporation (the “Amendment”) to effect a reverse stock split of the Company’s common stock at a ratio of one-for-twenty (the “Reverse Stock Split”) with the Secretary of State of the State of Delaware. The Amendment did not change the number of authorized shares, or the par value, of the Company’s common stock. The Amendment provides that the Reverse Stock Split becomes effective on February 23, 2018 at 5:00 p.m., at which time every twenty shares of the Company’s issued and outstanding common stock will automatically be combined into one issued and outstanding share of the Company’s common stock.
From December 31, 2015 to December 31, 2016
Compensation on options and restricted stock issued
from April 30, 2015 to December 31, 2015
Compensation on options and restricted stock issued
from April 30, 2014 to April 30, 2015
Compensation on options and restricted stock issued
Common stock issued for services rendered
Common stock issued as interest on convertible debt
Exercise of warrants
from April 30, 2013 to April 30, 2014
Preferred stock sold, net of offering costs
Preferred stock issued for convertible debt
Common and preferred stock issued for asset purchase
Common stock sold, net of offering costs
Common stock issued for convertible preferred stock
Common stock issued as interest on convertible debt
Common stock issued as dividend on convertible preferred stock
Compensation on options and restricted stock issued
Common stock issued for services rendered
Exercise of warrants
Fractional shares of common stock due to reverse stock split
1-for-20 reverse stock split effective May 10, 2013
from April 30, 2012 to May 13, 2013
Preferred stock sold, net of offering costs
Common stock issued for convertible preferred stock
Common stock issued as interest on convertible debt
Common stock issued as dividend on convertible preferred stock
Compensation on options and restricted stock issued
Issuance of warrants
Exchange of warrants
Fractional shares of common stock due to reverse stock split
As of June 3, 2013, we have regained compliance with the minimum $1.00 bid price requirement, due in part to our 20-to-1 reverse stock split effected on May 10, 2013.
from April 30, 2011 to April 30, 2012
Common stock sold, net of offering costs
Common stock issued for convertible preferred stock
Common stock issued as interest on convertible debt
Common stock issued as dividend on convertible preferred stock
Compensation on options and restricted stock issued
Exercise of warrants and options
from April 30 2010 to April 30 2011
Common stock sold, net of offering costs
Common stock issued for convertible debt
Issuance of common stock to employees
Exercise of warrants and options
from April 30, 2009 to April 30, 2010
Common stock sold, net of offering costs
Common stock issued for convertible debt
Issuance of common stock to employees
Issuance of common stock for services rendered
Exchange of warrants
Exercise of warrants and options
Fractional shares of common stock due to reverse stock split